See the Glossary for more terms.
Newest entries appear at the top of the list. For other NIH Guide policy notices, see Special Announcements.
Starting on October 1, 2014, NIH-supported research may not use NIH funds to procure or use dogs from Class B ("random source") dealers. Instead, researchers must use only approved legal sources, such as the following:
For more information and background, see the December 17, 2013, Guide notice.
Starting with the January 25, 2014, due date, researchers may propose work involving chimpanzees or biomaterials from chimpanzees.
For research not funded by NIH, third parties may request permission to use NIH-owned or -supported chimpanzees. NIH will consider third-party requests starting in March 2014.
After peer review, NIH requires investigators to complete a Chimpanzee Research Use Form unless their work is exempt. The form goes to NIH's Council of Councils for review and approval by a Chimpanzee Research Use Panel. Due to these additional steps, successful applicants should expect to wait at least a year for an award.
For more information, see the following:
NIH issued policy guidance for the following people affected by October's government shutdown:
For more information and links to relevant Guide notices, see NIH's Resuming Extramural Activities After the 2013 Government Shutdown.
NIH is delaying the transition to Payment Management System (PMS) subaccounts for domestic noncompeting continuation awards until FY 2015. All other domestic award types will transition to the PMS by the end of FY 2014 as planned.
Previously, NIH used pooled PMS accounts representing multiple grant awards. Under the new approach, grantees can draw down PMS funds only from a single grant subaccount and the available funds in that subaccount.
See the September 26, 2013, Guide notice for more details on the revised implementation timeline.
For more information, including how this affects carryover of funds, read the September 3, 2013, Guide notices:
NIH announced it is implementing the United States Government Policy for Oversight of Life Sciences Dual Use Research of Concern, which requires federal agencies to continually monitor funded research for dual use research potential and in cases of DURC, work with institutions and investigators to develop an appropriate risk mitigation plan.
At NIH, that plan may be a term of award after an administrative review of awards to determine if they involve DURC.
NIH may also request that institutions conduct periodic reviews of projects for their DURC potential and share with their program officer any resulting manuscripts before submitting them to journals.
For complete details, read the August 28, 2013, Guide notice.
NIH is phasing in a new policy that requires graduate and undergraduate students working on NIH-funded projects to set up eRA Commons IDs.
The implementation will begin as follows:
For more information, read the August 2, 2013, Guide notice and our September 4, 2013, article "Take Note of Notices Affecting Students and Postdocs."
Grantees must use the Research Performance Progress Report (RPPR) for streamlined noncompeting award process (SNAP) reports due on or after May 15, 2013.
SNAP no longer exists as a process, though some documents and systems may still use the term. eRA Commons will soon remove the eSNAP option from its progress reporting module.
Go to NIH's Research Performance Progress Report (RPPR) site for more information, including an instruction guide that explains how to submit RPPRs.
NIAID just released a new set of funding opportunity announcements (FOAs) for investigator-initiated clinical trials, published on March 22:
Applicants are strongly encouraged to request prior consultation with NIAID program staff at least 10 weeks before applying.
Find names of program staff in the relevant FOA's "Agency Contact" section under "Scientific/Research Contacts."
Applicants should also pay close attention to the "Responsiveness Criteria" section listed in the R01 and U01 FOAs. Applications must meet NIAID's expectations for responsiveness to proceed to peer review.
For more information, read the April 3, 2013, article "Heads Up: Investigator-Initiated Clinical Trials Opportunities."
Last Updated February 12, 2014
Last Reviewed February 12, 2014